Hickory/ Pecan Mix

CARYA ILLINOINENSIS POLLEN and CARYA OVATA POLLEN · CARYA OVATA POLLEN .05 g/mL; CARYA ILLINOINENSIS POLLEN .05 g/mL · Injection, Solution · Percutaneous · ALK-Abello, Inc.

NDC 00268-8028-06 · 5.5 mL in 1 VIAL · BLA · View full market →

The short version

Only one company currently supplies this market — there is no backup if it stumbles.

The numbers behind every sentence are on this page below — and the Watch button emails you when any of them move.

Medicare Part D

No Medicare Part D plan in CMS's quarterly files lists this product. That usually means it is discontinued, a repackager's listing, or a product no plan has added to its formulary.

How Part D pricing works →

NADAC price per unit

No NADAC pricing on file for this NDC — NADAC covers drugs dispensed by retail community pharmacies.

Supply fragility

Not scored — fragility is computed for NADAC-priced NDCs.

Is this a "specialty" drug?

There's no legal definition — it meets 2 of 6 public criteria. Why that matters →

Part D specialty tier
Costs ≥ $950/fill
Biologic (BLA)
Injectable / infused
Orphan-drug exclusivity
REMS program

Regulatory

Application: BLA103753
TE code: —
Approval date: —
Patents / exclusivity: None on file

Shortage history

No FDA shortage reports for this drug or its presentations.

Recalls (this NDC)

No enforcement reports list this package NDC.

Manufacturers of CARYA ILLINOINENSIS POLLEN and CARYA OVATA POLLEN (Injection, Solution)

Labeler	Strength	First seen	Last seen
ALK-Abello, Inc.	CARYA OVATA POLLEN .05 g/mL; CARYA ILLINOINENSIS POLLEN .05 g/mL	Jul 22, 2026	Sep 3, 2026
ALK-Abello, Inc.	CARYA ILLINOINENSIS POLLEN .05 g/mL; CARYA OVATA POLLEN .05 g/mL	Jul 15, 2026	Jul 18, 2026

Roster from daily NDC Directory diffs — first/last seen dates start July 2026.

Cite this page

DrugDashboards, "Hickory/ Pecan Mix — NDC 00268-8028-06," retrieved September 3, 2026, https://drugdashboards.com/drug/00268802806.

Free to cite with attribution — see how the data is put together.